Home › Funds › Patient Capital Management, LLC › GENI
Patient Capital Management, LLC position in GENI
GENIUS SPORTS LIMITED · Consumer Discretionary
Patient Capital Management, LLC reported holding 212,819 shares of GENI (GENIUS SPORTS LIMITED) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.04% of its reported portfolio and ranking #36 among its reported holdings. Patient Capital Management, LLC has disclosed GENI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Capital Management, LLC's GENI position evolved
Patient Capital Management, LLC first disclosed a stake in GENI in Q2 2026 at 812,819 shares (US$4.9M). Across 2 filings, Patient Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 212,819 shares valued at US$1.2M — a reduction of -600,000 shares quarter over quarter.. Notable position changes include a 74% trim in Q3 2026 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 812.82K | $4.93M | New |
| Q3 2026 | 212.82K | $1.22M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GENI and 13F data
GENI (GENIUS SPORTS LIMITED) is a Consumer Discretionary company. 22 other funds we track also report a position in GENI — the largest reported positions include Senvest Management, LLC (US$96.2M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$81.8M), SHAPIRO CAPITAL MANAGEMENT LLC (US$56.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GENI
- Senvest Management, LLC 15.88M sh · $96.24M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 13.50M sh · $81.78M · Q2 2026
- SHAPIRO CAPITAL MANAGEMENT LLC 9.79M sh · $56.10M · Q3 2026
- DISCOVERY CAPITAL MANAGEMENT, LLC / CT 7.23M sh · $43.82M · Q2 2026
- Portolan Capital Management, LLC 7.03M sh · $42.58M · Q2 2026
- Granahan Investment Management, LLC 7.02M sh · $42.57M · Q2 2026
- Voss Capital, LP 6.85M sh · $41.51M · Q2 2026
- NEEDHAM INVESTMENT MANAGEMENT LLC 4.92M sh · $29.85M · Q2 2026
- Samjo Management, LLC 4.91M sh · $29.77M · Q2 2026
- CYPRESS POINT INVESTMENT MANAGEMENT LP 4.15M sh · $25.16M · Q2 2026
- IFC Advisors LLC 4.05M sh · $24.56M · Q2 2026
More on Patient Capital Management, LLC
FAQ
How long has Patient Capital Management, LLC held GENI?
Patient Capital Management, LLC has disclosed GENI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Patient Capital Management, LLC's current position in GENI?
As of Q3 2026, Patient Capital Management, LLC holds 212.82K shares of GENI (GENIUS SPORTS LIMITED), valued at $1.22M, representing 0.04% of its reported portfolio and ranking #36.
Has Patient Capital Management, LLC been buying or selling GENI?
In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in GENI.
Which other funds hold GENI?
Other major institutional holders of GENI include Senvest Management, LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, SHAPIRO CAPITAL MANAGEMENT LLC, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.